happy 2016
高级会员
- 注册
- 2016-01-12
- 消息
- 1,010
- 荣誉分数
- 354
- 声望点数
- 93
以下的表格是加拿大最新批准的疫苗。根据WHO的资料目前全世界有200种疫苗在开发,其中60种已进入临床试验阶段。现在施打的最早出的这几种疫苗大多数的在紧逼的情况下生产出来的。新研发的疫苗是在有不断的学习,改进,超越的条件下研发出来的。有些CFC的朋友老要争目前的国产疫苗最好。不如把注意力放在新的疫苗上。中国也在研发新的疫苗,在亚州,越南,台湾也在研发。台湾7月开始量产2000万剂(每月)。年底出1.2亿,据说还一剂一针,方便注谢。这是不是事实,时间可以考验。钟南山和陈薇的新研发也一样,时间是考验。其实我想和大家分享一个最新看到的一个看法:现在加拿大缺疫苗,一年以后会有很多新的效力高的疫苗供选,到时疫苗的价格可能崩盘。 ““List of authorized drugs, vaccines and expanded indications for COVID-19.
Date modified: 2021-03-05
Report a problem or mistake on this page
Share this page
Date modified: 2021-03-05
Date modified: 2021-03-05
Authorization holder | Brand name, proper name or common name | DIN, medicinal ingredient(s), strength, dosage form, route of administration | Therapeutic area | Control number | Date of authorization or expanded indication | Authorization or expanded indication |
---|---|---|---|---|---|---|
AstraZeneca Canada Inc | AstraZeneca COVID-19 Vaccine ChAdOx1-S (recombinant) solution for injection | DIN 02510847 – 5x1010 VP/0.5 mL ChAdOx1-S (recombinant), 10-dose vial, solution, intramuscular administration DIN 02511444 – 5x1010 VP/0.5 mL ChAdOx1-S (recombinant), 8-dose vial, solution, intramuscular administration | Vaccines, for human use | 244627 | 2021-02-26 | Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions. |
BioNTech Manufacturing GmbH | Pfizer-BioNTech COVID-19 Vaccine Tozinameran (mRNA vaccine, BNT162b2) suspension for injection | DIN 02509210 – 30 mcg/0.3 mL tozinameran, suspension, intramuscular administration | Vaccines, for human use | 244906 | 2020-12-09 | Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions. |
Eli Lilly Canada Inc | Bamlanivimab Bamlanivimab solution for injection | DIN 02508176 - 700 mg/20 mL bamlanivimab, solution, intravenous administration | Immune sera and immunoglobulins, for human use | 244947 | 2020-11-20 | Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions. |
Gilead Sciences Canada Inc. | Veklury Remdesivir solution for injection | DIN 02502135 - 100 mg/20 mL remdesivir, solution, intravenous administration DIN 02502143 - 100 mg/vial remdesivir, powder for solution, intravenous administration | Antivirals for systemic use, for human use | 240551 | 2020-07-27 | Food and Drug Regulations. Issued Notice of Compliance under the NOC/c Guidance. |
Janssen Inc | Janssen COVID-19 Vaccine AD26.COV2.S (recombinant) suspension for injection | DIN 02513153 – 5x1010 VP/0.5 mL AD26.COV2.S (recombinant), suspension, intramuscular administration | Vaccines, for human use | 246758 | 2021-03-05 | Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions. |
Moderna Therapeutics Inc | COVID-19 Vaccine Moderna mRNA-1273 SARS-CoV-2 suspension for injection | DIN 02510014 – 100 mcg/0.5 mL mRNA-1273 SARS-CoV-2, suspension, intramuscular administration | Vaccines, for human use | 244946 | 2020-12-23 | Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions. |
Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) | Covishield ChAdOx1-S (recombinant) solution for injection | DIN 02512947 - 5x1010 VP/0.5 mL ChAdOx1-S (recombinant), 10-dose vial, solution, intramuscular administration | Vaccines, for human use | 248651 | 2021-02-26 | Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. Authorized with terms and conditions. |
Report a problem or mistake on this page
Share this page
Date modified: 2021-03-05